← All patents

US20100249038A1

Antagonists of the receptor for advanced glycation end-products (rage)

University of Texas System

Abstract

Novel peptides are useful as antagonists of RAGE and may be used to treat cancer, inflammation, diabetes and arthritis through the administration of a therapeutically effective amount of the peptide to a subject in need thereof.

University
University of Texas System
Assignee
Board Of Regents, University Of Texas System
Inventor
Craig D. Logsdon
Priority date
June 12, 2007
Filing date
June 12, 2008
Publication date
September 30, 2010
Language
en
Metadata fetched
August 29, 2026 00:19